Indications for Biventricular ICD (CRT-D)
A biventricular ICD (CRT-D) is indicated for patients with LVEF ≤35%, sinus rhythm, LBBB with QRS ≥150 ms, and NYHA class II-IV symptoms on guideline-directed medical therapy, as this combination provides both resynchronization therapy to reduce mortality and hospitalizations while protecting against sudden cardiac death. 1
Class I Indications (Strongest Evidence)
Primary CRT-D Candidates
LVEF ≤35% with LBBB (QRS ≥150 ms): Patients in sinus rhythm with LBBB pattern, QRS duration ≥150 ms, and NYHA class II, III, or ambulatory IV symptoms on optimized GDMT should receive CRT-D to reduce total mortality, hospitalizations, and improve symptoms and quality of life. 1
High ventricular pacing requirement: For patients with LVEF ≤35% undergoing new or replacement device implantation who require >40% ventricular pacing, CRT-D is indicated to prevent pacing-induced cardiomyopathy and reduce mortality. 1
Class IIa Indications (Reasonable to Use)
Intermediate QRS Duration
- LBBB with QRS 120-149 ms: In patients with LVEF ≤35%, sinus rhythm, LBBB pattern with QRS duration 120-149 ms, and NYHA class II, III, or ambulatory IV symptoms on GDMT, CRT-D is reasonable to reduce mortality and hospitalizations. 1, 2
Complete Heart Block with Preserved EF
- LVEF 36-50% with complete heart block: CRT-D (or CRT-P) is reasonable for patients with high-degree or complete heart block and LVEF 36-50% to prevent pacing-induced cardiomyopathy and improve clinical outcomes. 1, 2
Atrial Fibrillation Patients
- AF with LVEF ≤35%: CRT-D can be useful in patients with atrial fibrillation who meet standard CRT criteria, provided that either AV nodal ablation is performed or pharmacological rate control achieves near 100% ventricular pacing with CRT. 1
Class IIb Indications (May Be Considered)
Non-LBBB Patterns
- Non-LBBB with QRS 120-149 ms: For patients with LVEF ≤35%, sinus rhythm, non-LBBB pattern with QRS 120-149 ms, and NYHA class III or ambulatory IV symptoms on GDMT, CRT-D may be considered, though evidence is weaker than for LBBB patterns. 1
Asymptomatic Ischemic Cardiomyopathy
- NYHA class I with ischemic etiology: For patients with LVEF ≤30%, ischemic heart failure, sinus rhythm, LBBB with QRS ≥150 ms, and NYHA class I symptoms on GDMT, CRT-D may be considered to reduce future hospitalizations. 1
Genetic Arrhythmogenic Cardiomyopathy
- High-risk genetic cardiomyopathy: In patients with genetic arrhythmogenic cardiomyopathy with high-risk features of sudden death and EF ≤45%, ICD (which may be combined with CRT if other criteria are met) is reasonable to decrease sudden death. 1
Absolute Contraindications
QRS Duration Threshold
- QRS <120 ms: CRT-D is not recommended in patients with QRS duration <120 ms, regardless of echocardiographic evidence of dyssynchrony, as clinical trials have shown no benefit and potential harm. 1, 3
Symptom and QRS Combinations
- NYHA I-II with non-LBBB and QRS <150 ms: CRT-D is not recommended for patients with NYHA class I or II symptoms and non-LBBB pattern with QRS <150 ms due to lack of demonstrated benefit. 1
Limited Life Expectancy
- Survival <1 year: For patients whose comorbidities or frailty limit survival with good functional capacity to <1 year, CRT-D is not indicated as they will not derive meaningful benefit. 1
Critical Decision-Making Algorithm
Step 1: Verify LVEF and Optimize GDMT
- Confirm LVEF ≤35% (or 36-50% for complete heart block) after at least 3 months of optimal guideline-directed medical therapy, as LVEF may improve with medical optimization alone. 1
Step 2: Assess QRS Duration and Morphology
- Measure QRS duration on 12-lead ECG; strongest evidence exists for LBBB morphology with QRS ≥150 ms, with decreasing benefit as QRS shortens or with non-LBBB patterns. 1, 2
Step 3: Evaluate Rhythm
- Sinus rhythm provides optimal CRT response; for atrial fibrillation patients, plan for AV nodal ablation or aggressive rate control to ensure near 100% biventricular pacing. 1
Step 4: Assess Functional Status
- NYHA class II-IV symptoms indicate clear benefit; class I may benefit only if ischemic etiology with LVEF ≤30% and LBBB with QRS ≥150 ms. 1
Step 5: Determine ICD vs CRT-P
- Choose CRT-D over CRT-P for patients meeting both CRT criteria and ICD criteria (primary prevention with LVEF ≤35% or secondary prevention after cardiac arrest/sustained VT). 3
Common Pitfalls and Caveats
Timing of Implantation
- Avoid during acute decompensation: Do not implant CRT-D during admission for acute decompensated heart failure; optimize GDMT first and reassess LVEF after stabilization. 2
Pacing Percentage Requirements
- Ensure high biventricular pacing: CRT-D benefit requires near 100% biventricular pacing; inadequate pacing percentage (<95-98%) negates the benefit, particularly in atrial fibrillation patients without adequate rate control. 1, 2
Right Ventricular Pacing-Induced Cardiomyopathy
- Upgrade existing pacemakers: Patients with conventional right ventricular pacemakers who develop heart failure with LVEF ≤35% and high percentage ventricular pacing should be upgraded to CRT-D if they remain NYHA class III-IV despite adequate medical treatment. 2
QRS Morphology Matters
- LBBB provides greatest benefit: The strongest evidence for CRT-D benefit exists in patients with typical LBBB morphology; non-LBBB patterns show less consistent benefit even with prolonged QRS duration. 2